Patient DischargeNCT07588542
PACU Discharge Readiness
A study testing custom-created apps, neuropsychological testing, and clinical assessments in people with Patient Discharge and Neurocognition, run by University of Illinois at Chicago at 1 site in United States.
Trial summary
The use of custom-created apps, neuropsychological testing, and clinical assessments will be evaluated as tools for determining the appropriateness of PACU discharge to home. Read more about this study
- Who is it for?
- Ages 18 years and older
- Conditions the study is for
- Patient Discharge, Neurocognition, Baseline
- What is being tested?
- custom-created apps, neuropsychological testing, and clinical assessments
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 1,000 participants
- Where
- 1 siteUnited States
- Study dates
- 15 Oct 2026to 1 Apr 2032
- Phase
- Interventional
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- No healthy volunteers
- Adult, Older adult
Who may be able to join
- The individuals will be identified from the operating room (OR) schedule and approached in the pre-operative area (or earlier, when possible).
- Adult patients (18 years or older) listed for surgery and a planned 23-hour admission will be eligible for enrollment in this study.
- Subjects must be fluent in English and not have confounding sensory or neurological limitations to participation
Who cannot join
- Members of vulnerable populations or adults unable to consent will be included in this study.
- Subjects that do not speak English
- Subjects with neurological limirations
Trial locations and contacts
1 site in 1 country. Contact the study team or a site near you to ask about taking part.
United States1 site
University of Illinois Chicago
Chicago, Illinois, 60612
About this study
Official title: Development of Assessment Tools for Determining Outpatient Subjects' Home-Readiness After Receiving Anesthesia (Without Family or Friend to Drive Them Home)
The use of custom-created apps, neuropsychological testing, and clinical assessments will be evaluated as tools for determining the appropriateness of PACU discharge to home.
- Conditions
- Patient Discharge, Neurocognition, Baseline
- Being tested
- custom-created apps, neuropsychological testing, and clinical assessments
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
custom-created apps, neuropsychological testing, and clinical assessmentsDiagnostic test
This study's interventions will include a brief neuropsychological assessment, including pre-operative baseline and post-operative repeat assessment. Additional assessments of memory and coordination using two custom apps and standard clinical assessments will also be conducted at each timepoint
| Study group | Role | What they receive |
|---|---|---|
| Neuro Assessment Group | Experimental | Not described Receives: Diagnostic Test: custom-created apps, neuropsychological testing, and clinical assessments |
What is being measured
The primary outcome is the main question the study is designed to answer.
Standardized neuropsychiatric testing WAIS SCWT SPWT TOPJ
comparison of results to baseline measurements of these four validated neuropsychiatric assessments
Measured: 24 hours
Secondary outcomes (2)
Memory App
Use of a colored sequence presentation memory app to assess subjects return to baseline
Measured: 24 hours
Flight Path App
Seated subject follows the flight path of a bird on an iPad app. Comparisons made to baseline performance.
Measured: 24 hours
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted14 May 2026
- Study start15 Oct 2026 (estimated)
- Primary completion1 Apr 2031 (estimated)
- Study completion1 Apr 2032 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Patient DischargeStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Health services research
- Allocation
- Not applicable
- Intervention model
- Single group
- Masking
- None (open label)
- Enrolment
- 1,000 participants (estimated)
Sponsor and investigators
- Lead sponsor
- University of Illinois at Chicago
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, David Glick, University of Illinois at Chicago
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07588542
- Sponsor's protocol ID
- 2025-1331
- Status last verified
- Oct 2026
- First submitted
- 20 Mar 2026
- Last updated
- 9 Oct 2026
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- Undecided
Study at a glance
From the registry record, last updated by the sponsor on 9 Oct 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Development of Assessment Tools for Determining Outpatient Subjects' Home-Readiness After Receiving Anesthesia (Without Family or Friend to Drive Them Home)
- ClinicalTrials.gov ID
- NCT07588542
- Acronym / sponsor ID
- 2025-1331
- Conditions
- Patient Discharge, Neurocognition, Baseline
- Study type
- Interventional
- Recruitment status
- Not yet recruiting
- Enrolment
- 1,000 participants (estimated)
- Lead sponsor
- University of Illinois at ChicagoUniversity, hospital or other
- Study start
- 15 Oct 2026 (estimated)
- Primary completion
- 1 Apr 2031 (estimated)
- Study completion
- 1 Apr 2032 (estimated)
- First posted
- 14 May 2026 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The use of custom-created apps, neuropsychological testing, and clinical assessments will be evaluated as tools for determining the appropriateness of PACU discharge to home.
Study design
- Primary purpose
- Health services research
- Allocation
- Not applicable
- Intervention model
- Single group
- Masking
- None (open label)
- Number of arms
- 1
| Arm | Type | Receives |
|---|---|---|
| Neuro Assessment Group | Experimental | Diagnostic Test: custom-created apps, neuropsychological testing, and clinical assessments |
Who may qualify
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (3 listed)
- The individuals will be identified from the operating room (OR) schedule and approached in the pre-operative area (or earlier, when possible).
- Adult patients (18 years or older) listed for surgery and a planned 23-hour admission will be eligible for enrollment in this study.
- Subjects must be fluent in English and not have confounding sensory or neurological limitations to participation
Key exclusion criteria (3 listed)
- Members of vulnerable populations or adults unable to consent will be included in this study.
- Subjects that do not speak English
- Subjects with neurological limirations
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| custom-created apps, neuropsychological testing, and clinical assessmentsThis study's interventions will include a brief neuropsychological assessment, including pre-operative baseline and post-operative repeat assessment. Additional assessments of memory and coordination using two custom apps and standard clinical assessments will also be conducted at each timepoint | Diagnostic test | Neuro Assessment Group |
Primary outcome
Standardized neuropsychiatric testing WAIS SCWT SPWT TOPJ
Time frame: 24 hours
comparison of results to baseline measurements of these four validated neuropsychiatric assessments
2 secondary outcomes
Memory App
Time frame: 24 hours
Flight Path App
Time frame: 24 hours
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 9 Oct 2026.
- Individual participant dataSharing planned: Undecided
Related trials for Patient Discharge
Not yet recruiting
A Clinical Trial to Evaluate the Effects of the NeuEve Dryness Treatment Kit on Vaginal Health, Comfort, and Quality of Life in Postmenopausal Women
Relieves Vaginal Dryness / Improves Self-Lubrication, Improves Strength & Elasticity of Vagina (Aka Collagen and Elastin)
Active, not recruiting
Diabetes Toolkit at Discharge
Diabetes Mellitus, Type 2, Insulin Dependent Diabetes
Not yet recruiting
Transitioning Recently Admitted Patients With Non-Insulin and Insulin-treated Type 2 Diabetes to Innovative Glucose Monitoring
Type 2 Diabetes
RecruitingPhase 2/3
Efficacy and Safety of Oral Controlled-Ileocolonic-Release Nicotinamide (CICR-NAM) in Patients With Mild to Moderately Active Ulcerative Colitis
Ulcerative Colitis, Unspecified
Not yet recruitingObservational study
ADVANCE-FORSEE. ADVANCEd Video Monitoring FOR Early Signaling of Adverse Events and Optimal dischargE Planning.
Vital Signs Monitoring, Complication
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing custom-created apps, neuropsychological testing, and clinical assessments in people with Patient Discharge and Neurocognition, run by University of Illinois at Chicago at 1 site in United States.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 3 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: opening soon, as of the sponsor's last update on 9 Oct 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
Contact Alexandra Barabanova (312-355-5377, barabano@uic.edu), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Standardized neuropsychiatric testing WAIS SCWT SPWT TOPJ (time frame: 24 hours). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 9 Oct 2026.